Phase
Condition
Vascular Diseases
Diabetes Prevention
Metabolic Syndrome
Treatment
coenzyme Q10
placebo
Clinical Study ID
Ages 30-90 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Metabolic syndrome or high-risk groups with metabolic syndrome are defined assubjects with metabolic syndrome according to the International Diabetes Federation (IDF) Chinese Adult Criteria, and high-risk groups are defined as those who meet atleast two MetS risk factors. The specific criteria are as follows:
Aged 30-90 years old;
Two or more of following are acceptable:
Abdominal obesity (central obesity): waist circumference >=90 cm for men and >=80cm for women;
Hyperglycemia: fasting blood glucose ≥ 5.6mmol/L or taking hypoglycemic drugs;
Hypertension: systolic blood pressure >=130mmHg and (or) diastolic bloodpressure >=85mmHg or taking blood pressure medications;
Fasting TG>=1.70mmol/L or taking antihyperlipidemic drug;
Fasting HDL-C<1.04 mmol/L for men, <1.29 mmol/L for women or takingantihyperlipidemic drug; 3) Sign informed consent and insist on participatingin the research.
Exclusion
Exclusion Criteria:
- Take drugs/dietary supplements, such as aspirin, fish oil and etc., that affectplatelet function in recently six months; 2) blood system disease or infection;
- Blood pressure >=160/100mmHg; 4) Low platelet count (whole bloodplatelet<100 x 10^9/mL); 5) Abnormal hemoglobin (male <120g/L, female <110g/L);
- Low hematocrit (male <40%, female <37%); 7) Prothrombin time (PT) is outsidethe normal reference range; 8) Pregnant women or nursing mothers; 9) Abnormalmenstrual cycle, taking birth control pills or hormone replacement therapy; 10)Gastric ulcer, liver or kidney dysfunction.
Study Design
Connect with a study center
School of Public Health (Shenzhen), Sun Yat-sen University
Shenzhen, 518107
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.